SAN DIEGO, Sept. 26, 2016 /PRNewswire/ -- Biocom, the association representing the California life science community, today announced the winners of its inaugural Life Science Catalyst Awards, presented in conjunction with the San Diego Venture Group.
The program celebrates up-and-coming academics, entrepreneurs, investors, corporate leaders and business advisers who are making a lasting and positive mark on San Diego's life science industry before reaching their 40th birthday.
"The recipients of the Life Science Catalyst Awards represent the future of our biotechnology industry — a future that's extremely exciting," said Joe Panetta, president and CEO of Biocom. "These inspiring individuals are leading the growth of life sciences in San Diego and beyond, and are actively shaping what our industry will look like tomorrow. Biocom congratulates them for their achievements."
Biocom selected the 10 winners from an impressive pool of nominees that included professionals from a wide range of life science organizations, from publicly held biotech companies to universities and consultancies. Each nominee was vetted by a committee of Biocom and San Diego Venture Group board and committee members, evaluating factors such as innovation, leadership and vision. In addition, 10 nominees received honorable mentions.
Listed in alphabetical order, the Biocom Life Science Catalyst Award winners are:
Phil Baran, professor and Darlene Shiley Chair in Chemistry, The Scripps Research Institute
Martyn Gross, chief executive officer, Clarify Medical
Tony Grover, vice president, business development, Banyan Biomarkers
Susie Harborth, general partner, BioInnovation Capital, managing director, BioLabs San Diego
Michael Heltzen, chief executive officer, AllSeq
Rob Knight, faculty director, Center for Microbiome Innovation Pediatrics, computer science and engineering, University of California, San Diego
Dena Marrinucci, vice president of research, Salveo Dx
Mike Milligan, principal, life science department, Barney & Barney
Ed Truitt, co-founder and chief executive officer, Lubris BioPharma
Ashley Van Zeeland, chief technology officer, Human Longevity
Nominees receiving honorable mention are:
Francie Barron, vice president of biology, Nanomedical Diagnostics
Sanjeev Bhavnani, physician-investigator at Scripps Clinic and Research Institute
Brenden Eckelmen, vice president, scientific operations for Inhibrx
Thomas Hitchcock, founder and chief executive officer, Xycrobe Therapeutics
Jonathan Kabakoff, senior principal, science and technology, Alexandria Venture Investments/Alexandria Real Estate Equities
Prashant Mali, assistant professor of bioengineering, University of California, San Diego
David Puerta, chief operating officer, Forge Therapeutics
Ryan Taft, senior director, scientific research, Illumina
Dina Uzri, R&D and business development, Abreos Biosceicnes
The award winners will be featured in the fall edition of Biocom's LifeLines magazine and will be guests of honor at an awards reception hosted by Biocom's board of directors at celebrity chef Brian Malarkey'sTorrey Pines restaurant, Farmer & The Seahorse. For more information on the winners, visit https://www.biocom.org/s/Catalyst-Awards.
"More than 30 years after the beginnings of San Diego's biotech industry, it's appropriate to recognize an entirely new generation of life science leaders who are building on our city's rich legacy of innovation while also carving their own path," said Mike Krenn, president of the San Diego Venture Group, a nonprofit organization focused on supporting San Diego's innovation economy. "The San Diego Venture Group applauds the passion, creativity and direction that these men and women bring to life science."
Biocom is the largest, most experienced leader and advocate for California's life science sector. We work on behalf of more than 800 members to drive public policy, build an enviable network of industry leaders, create access to capital, introduce cutting-edge STEM education programs and create robust value-driven purchasing programs.
Founded in 1995 in San Diego, Biocom provides the strongest public voice to research institutions and companies that fuel the local and state-wide economy. Our goal is simple: to help our members produce novel solutions that improve the human condition. In addition to its San Diego headquarters, Biocom operates a core office serving the Los Angeles market, satellite offices in Washington, D.C. and Tokyo, and has a continuous staff presence in Sacramento. Our broad membership benefits apply to biotechnology, pharmaceutical, medical device, genomics and diagnostics companies of all sizes, as well as to research universities and institutes, clinical research organizations, investors and service providers. For more information, visit us at www.biocom.org. Connect with us on LinkedIn, Facebook, and Twitter (@BIOCOMCA).